Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
Chemicals AmericaChemicals America
Not Confirmed
Not Confirmed
29-31 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Chemicals AmericaChemicals America
Industry Trade Show
Not Confirmed
29-31 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
24 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250724096451/en/Nuvation-Bio-to-Report-Second-Quarter-2025-Financial-Results-and-Provide-Business-Update-on-August-7-2025
24 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250624605890/en/Nuvation-Bio-Announces-National-Comprehensive-Cancer-Network-Adds-Taletrectinib-IBTROZI-as-Preferred-Option-to-Clinical-Practice-Guidelines-in-Oncology-for-Advanced-ROS1-Non-Small-Cell-Lung-Cancers
16 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/16/3099726/0/en/Onco360-Has-Been-Selected-as-a-National-Specialty-Pharmacy-Partner-for-IBTROZI-taletrectinib-Manufactured-by-Nuvation-Bio-Inc.html
12 Jun 2025
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-nuvation-bios-lung-cancer-therapy-2025-06-11/
21 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250521881222/en/Nuvation-Bio-To-Present-New-Data-from-Pivotal-Clinical-Studies-of-Taletrectinib-in-Advanced-ROS1-Positive-Non-Small-Cell-Lung-Cancer-at-ASCO-2025-Annual-Meeting
13 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250513735131/en/Nuvation-Bio-to-Present-Matching-adjusted-Indirect-Comparison-Data-for-Taletrectinib-vs.-Entrectinib-at-ISPOR-2025
ABOUT THIS PAGE